CROs / Osage University Partners / Accelerating Commercial Development/Innovation Fund / Third Rock Ventures / Syncona Partners / CRO Partnerships / Fast Forward LLC / Evotec / /
Continent
America / /
Country
United States / Canada / United Kingdom / /
Currency
USD / / /
Facility
California Institute / European Lead Factory / /
IndustryTerm
venture capital / Therapeutics for Rare and Neglected Diseases / pharmaceutical / pharmaceutical industry partnerships / /
NaturalFeature
Valley of Death / /
Organization
Commercial Development/Innovation Fund for Multiple Sclerosis / National Institute of Health / National Venture Capital Association / MIT / Center for Venture Research / California Institute for Regenerative Medicine / Kauffman Foundation / /
Person
Steve Dickman / Andrew Lo / / /
Position
CBT Advisors / Advisors / Executive / Major Research Universities / /
PublishedMedium
Fast Forward / /
RadioStation
2013 CBT / /
Technology
CBT / Cell Therapy / drug development / Regenerative Medicine / /
Investing in translational research to produce clinical, commercial and financial outcomes: Current and future mechanisms A White Paper for CIRM by Steve Dickman and the team at CBT Advisors